SCHEMBL12379532

SCHEMBL12379532

CN(C)CCNC(=O)CC1CC2C3CCc4cc(O)ccc4C3CC[C@]2(C)C1=O

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 12/20 0.76
ESR1 P03372 4/20 0.52
ESR2 Q92731 3/20 0.52
CYP3A4 P08684 2/20 0.52
MAPT P10636 2/20 0.52
AKR1B10 O60218 1/20 0.52
LMNA P02545 1/20 0.52
SHBG P04278 1/20 0.52
CYP1A2 P05177 1/20 0.52
PGR P06401 1/20 0.52
SERPINA6 P08185 1/20 0.52
STS P08842 1/20 0.52
AR P10275 1/20 0.52
CYP19A1 P11511 1/20 0.52
AKR1B1 P15121 1/20 0.52
NFKB1 P19838 1/20 0.52
SLC6A4 P31645 1/20 0.52
OPRM1 P35372 1/20 0.52
SNCA P37840 1/20 0.52
HTR2B P41595 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12379529 0.95 HSD17B1 (0.73) HSD17B1ESR1ESR2CYP3A4MAPT
SCHEMBL12379557 0.88 HSD17B1 (0.82) HSD17B1ESR1ESR2CYP3A4MAPT
SCHEMBL12379530 0.88 HSD17B1 (0.76) HSD17B1ESR1ESR2CYP3A4MAPT
SCHEMBL12379562 0.86 HSD17B1 (1.00) HSD17B1ESR1ESR2CYP3A4MAPT
SCHEMBL12379559 0.84 HSD17B1 (0.81) HSD17B1ESR1ESR2CYP3A4MAPT
SCHEMBL12593969 0.83 HSD17B1 (0.80) HSD17B1ESR1ESR2CYP3A4MAPT
SCHEMBL12379508 0.83 HSD17B1 (0.80) HSD17B1ESR1ESR2CYP3A4MAPT
SCHEMBL12379796 0.83 HSD17B1 (0.68) HSD17B1ESR1ESR2CYP3A4MAPT
SCHEMBL12418958 0.83 HSD17B1 (0.82) HSD17B1ESR1ESR2CYP3A4MAPT
SCHEMBL12379549 0.82 HSD17B1 (0.75) HSD17B1ESR1ESR2CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8003783-B2 Steroid 17 beta -hydroxysteroid dehydrogenase inhibitors substituted with one or more oxime groups, especially aromatase inhibitors used in the treatment of endocrine-dependent tumors, especially breast cancer STERIX LIMITED (GB) 2011-08-23 US disclosed
US-8003783-B2 Steroid 17 beta -hydroxysteroid dehydrogenase inhibitors substituted with one or more oxime groups, especially aromatase inhibitors used in the treatment of endocrine-dependent tumors, especially breast cancer STERIX LIMITED (GB) 2011-08-23 US disclosed
EP-2336146-A1 17beta-hydroxysteroid dehydrogenase inhibitors Sterix Limited (GB) 2011-06-22 EP disclosed